Vanguard Fiduciary Trust
ALLR

Vanguard Fiduciary Trust’s Allarity Therapeutics ALLR Stock Holding History

Vanguard Fiduciary Trust’s Portfolio ALLR Stock Details ALLR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$96.6K Hold
74,913
– – ﹤0.01% 3746
2026
Q1 		$81.7K Buy
+74,913
New +$80.6K ﹤0.01% 3745

Other funds holding ALLR

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MCM
Militia Capital Management Austin, Texas $3.37B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Fiduciary Trust's ALLR Position: Q2 2026 in Review

Vanguard Fiduciary Trust held its Allarity Therapeutics (ALLR) position steady in Q2 2026 at 74,913 shares worth $96.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3746.

Vanguard Fiduciary Trust first reported a position in ALLR in Q1 2026 and has held it in 2 quarters since. 20 funds tracked by Wall St. Rank hold ALLR as of Q2 2026.

  • Vanguard Fiduciary Trust held 74,913 shares of Allarity Therapeutics worth $96.6K as of Q2 2026.
  • Vanguard Fiduciary Trust left its Allarity Therapeutics share count unchanged in Q2 2026.
  • Allarity Therapeutics made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3746 holding.
  • Vanguard Fiduciary Trust first reported a position in Allarity Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 20 funds tracked by Wall St. Rank held Allarity Therapeutics as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.